Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets

Neurosci Lett. 1992 Dec 14;148(1-2):137-40. doi: 10.1016/0304-3940(92)90823-p.

Abstract

Tumor necrosis factor alpha (TNF alpha) plays a significant role in the pathogenesis of central nervous system infections. We investigated the effect of intracisternal injection of recombinant human TNF alpha (50-50,000 IU) on pial vasoreactivity and blood-brain barrier permeability in newborn piglets. The cytokine administration resulted in arterial vasoconstrictions, blood-brain barrier opening for Na-fluorescein (mol. wt. 376 Da) and increased Na-fluorescein uptake in brain regions examined (parietal and occipital cortex, cerebellum, pons/medulla, periventricular white matter) in a dose-dependent manner. TNF alpha may be involved in the pathophysiology of neonatal brain injuries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Arterioles / drug effects
  • Arterioles / physiology*
  • Blood-Brain Barrier / drug effects*
  • Brain / drug effects
  • Brain / metabolism
  • Female
  • Humans
  • Injections
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology
  • Pia Mater / blood supply*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Subarachnoid Space
  • Swine
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Vasoconstriction / drug effects*

Substances

  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha